The owner and head of the Russian drug company Ferane says he sees nofuture for the domestic pharmaceutical industry "the way things are" and has admitted he would be prepared to sell his company "if the offer was good."
Vladimir Bryntsalov says the Russian drug market is now "ruled by transcontinental foreign companies that buy out Russian enterprises for a song." Domestic producers are left to their own devices with no significant legal or state support.
He says domestic drug production is crippled by a wrong policy on taxes. These swallow whatever profits are earned, leaving producers with no incentive to continue let alone expand their businesses. The government must regulate price formation and do everything to raise industry wages at the expense of private-sector profits.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze